These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24080440)

  • 21. Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies.
    Nadal R; Lorente JA; Rosell R; Serrano MJ
    Expert Rev Mol Diagn; 2013 Apr; 13(3):295-307. PubMed ID: 23570407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer stem cells: implications for cancer therapy.
    Dawood S; Austin L; Cristofanilli M
    Oncology (Williston Park); 2014 Dec; 28(12):1101-7, 1110. PubMed ID: 25510809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer defeating? Challenge accepted!
    Di Franco S; Todaro M; Dieli F; Stassi G
    Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translating basic research in cancer patient care.
    Maugeri-Saccà M; De Maria R
    Ann Ist Super Sanita; 2011; 47(1):64-71. PubMed ID: 21430342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanomaterials for targeted drug delivery to cancer stem cells.
    Orza A; Casciano D; Biris A
    Drug Metab Rev; 2014 May; 46(2):191-206. PubMed ID: 24697156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colon cancer stem cells--from basic to clinical application.
    Botchkina G
    Cancer Lett; 2013 Sep; 338(1):127-40. PubMed ID: 22537805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.
    Ceppi P; Peter ME
    Oncogene; 2014 Jan; 33(3):269-78. PubMed ID: 23455327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer stem cells: the development of new cancer therapeutics.
    Scatena R; Bottoni P; Pontoglio A; Giardina B
    Expert Opin Biol Ther; 2011 Jul; 11(7):875-92. PubMed ID: 21463158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular-targeted therapies: lessons from years of clinical development.
    Rosa DD; Ismael G; Lago LD; Awada A
    Cancer Treat Rev; 2008 Feb; 34(1):61-80. PubMed ID: 17826917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells.
    Deng H; Yin L; Zhang XT; Liu LJ; Wang ML; Wang ZY
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():417-26. PubMed ID: 25158023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biology and clinical applications of pancreatic cancer stem cells.
    Abel EV; Simeone DM
    Gastroenterology; 2013 Jun; 144(6):1241-8. PubMed ID: 23622133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy.
    Sukowati CH; Tiribelli C
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):749-57. PubMed ID: 24161136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can lung cancer stem cells be targeted for therapies?
    Wu X; Chen H; Wang X
    Cancer Treat Rev; 2012 Oct; 38(6):580-8. PubMed ID: 22436486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoplastic stem cells: a novel therapeutic target in clinical oncology.
    Schulenburg A; Ulrich-Pur H; Thurnher D; Erovic B; Florian S; Sperr WR; Kalhs P; Marian B; Wrba F; Zielinski CC; Valent P
    Cancer; 2006 Nov; 107(10):2512-20. PubMed ID: 17039500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer stem cells niche: a target for novel cancer therapeutics.
    Yi SY; Hao YB; Nan KJ; Fan TL
    Cancer Treat Rev; 2013 May; 39(3):290-6. PubMed ID: 23219150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia as a biomarker for radioresistant cancer stem cells.
    Peitzsch C; Perrin R; Hill RP; Dubrovska A; Kurth I
    Int J Radiat Biol; 2014 Aug; 90(8):636-52. PubMed ID: 24844374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma.
    van der Horst G; Bos L; van der Pluijm G
    Mol Cancer Res; 2012 Aug; 10(8):995-1009. PubMed ID: 22714124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New treatment strategies targeting cancer stem cells].
    Li M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):546-50. PubMed ID: 25360656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.